Kritoma

Discovery

Explore Topics Papers

Docs Terms Privacy

Search Kritoma

Recent searches

Searches you run from this bar will appear here.

CAR-T and engineered T cell therapies

Clinical MedicineUpdated Oct 5, 2026Version v1

Knowledge Timeline Gaps (1)Evidence (307)Community (0)

Evidence

Public papers linked to this topic and used as evidence for gaps, timelines, and knowledge views.

307 papers

SearchSort evidence

All307 Core249 Supporting83 Background0

Showing 13-24 of total 307 evidence records.

Open a paper to inspect abstract, source links, and topic context.

2026PubMedDirectly related

Engineered CAR-T extracellular vesicles loaded with miR-17-5p inhibitor suppress hepatocellular carcinoma progression.

Zhou Z; Wu H; Zhao S; Chen M; Lin W; Li J; Zheng Q

Jan 1, 2026

Frontiers in immunology

2026PubMedDirectly related

Next-generation CAR-T cell therapy against cancer: precision engineering, programmable immunity, and emerging clinical frontiers.

Mustaffa FE; Aslam MS; Junaid M

Jan 1, 2026Journal of the Egyptian National Cancer Institute

2026PubMedDirectly related

CAR-T Cell Therapy: Engineering Remission in Refractory Myeloma.

Sperling AS

Jan 1, 2026Cancer journal (Sudbury, Mass.)

2026PubMedDirectly related

Co-expression of non-signaling CARs enhances EGFRvIII-specific CAR T-cell cytotoxicity against head and neck squamous cell carcinoma.

Grueter K; Sander N; Coen L; Hüsken S; Kleinfelder E; Haist C; Blaeschke F; Scheckenbach K; Monzel C; Hanenberg H; Wiek C

Jan 1, 2026BMC cancer

2026PubMedDirectly related

Recent advancements and persisting challenges in the evolution of next generation car t cell therapy for solid malignancies: a comprehensive review.

Waqar MA; Malik A; Mubarak N

Jan 1, 2026Immunologic research

2026PubMedDirectly related

Chimeric Antigen Receptor T Cell Therapy for Glioblastoma: Clinical Advances and Emerging Strategies.

Grewal EP; Ramapriyan R; Curry WT Jr; Choi BD

Jan 1, 2026Hematology/oncology clinics of North America

2026PubMedSupporting evidence

Ultrasound-Mediated CRISPR Delivery and Sonogenetic Modulation for Precision Therapeutics.

Maham S; Sridharan B; Park JH; Lee C; Park YS; Kim D; Sung Y; Kwon T; Kang J; Lim HG

Jan 1, 2026Advanced healthcare materials

2026PubMedDirectly related

A Multi-Targeting Chimeric Antigen Receptor-T Cell Platform to Overcome Antigen Heterogeneity in the Treatment of Non-Small Cell Lung Cancer.

Wang L; Zhang Y; Peng S; Hou C; Guo H; Zhou T; Chang AH; Yan L; Xiong W

Jan 1, 2026Advanced science (Weinheim, Baden-Wurttemberg, Germany)

2026PubMedDirectly related

Advancing In Vivo Chimeric Antigen Receptor T-Cell Engineering to Accelerate Clinical Translation.

Bai Z; Yi M; Hu S; Xue D; Wei L; Zhang L; Dai Z

Jan 1, 2026MedComm

2026PubMedSupporting evidence

Integrative scRNA-seq and scTCR-seq analyses decode dual TCR γδ T-cell characteristics in human and mouse.

Wang H; Xu Y; Cao N; Ma Q; Li J; Quan K; Yao X

Jan 1, 2026ImmunoHorizons

2026PubMedSupporting evidence

Changes in C-Reactive Protein Forecast Infection Risk Following Treatment with Chimeric Antigen Receptor T Cells.

Mathur P; Chen H; Riedel DJ; Holland E; Palacio D; Bork JT; Prakash K; Hardy N; Kocoglu M; Badros A; Fromowitz A; Yared J; Rapoport AP; Atanackovic D; Baddley J

Jan 1, 2026Cancers

2026PubMedDirectly related

Transient suppression of fibrinolytic potential during cytokine release syndrome after chimeric antigen receptor T-cell therapy in B-cell malignancies.

Ishihara T; Arai Y; Onishi T; Yamasaki-Morita M; Nagao M; Adachi S; Nogami K; Takaori-Kondo A

Jan 1, 2026Thrombosis research

Page 2 of 26Showing 13-24 of total 307 results.

123...26

CAR-T and engineered T cell therapies — Research Evidence and Topic Memory | Kritoma